SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15533848
Source:
http://linkedlifedata.com/resource/pubmed/id/15533848
Search
Subject
(
42
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026764
,
umls-concept:C0045093
,
umls-concept:C0205269
,
umls-concept:C0220825
pubmed:issue
11
pubmed:dateCreated
2004-11-9
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0417435
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine
,
http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1592-8721
pubmed:author
pubmed-author:BouafiaFadelaF
,
pubmed-author:DumontetCharlesC
,
pubmed-author:FaconThierryT
,
pubmed-author:LeleuXavierX
,
pubmed-author:MichalletMauricetteM
,
pubmed-author:TroncyJacquesJ
pubmed:issnType
Electronic
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
ELT15
pubmed:meshHeading
pubmed-meshheading:15533848-Adult
,
pubmed-meshheading:15533848-Aged
,
pubmed-meshheading:15533848-Aged, 80 and over
,
pubmed-meshheading:15533848-Antimetabolites, Antineoplastic
,
pubmed-meshheading:15533848-Deoxycytidine
,
pubmed-meshheading:15533848-Female
,
pubmed-meshheading:15533848-Humans
,
pubmed-meshheading:15533848-Male
,
pubmed-meshheading:15533848-Middle Aged
,
pubmed-meshheading:15533848-Multiple Myeloma
pubmed:year
2004
pubmed:articleTitle
Evaluation of gemcitabine in relapsed or refractory multiple myeloma.
pubmed:publicationType
Letter
,
Multicenter Study
,
Clinical Trial, Phase II